CAS 488847-28-5

Pyridine, 2-[(3,4-dihydro-2-phenyl-2H-1-benzopyran-6-yl)oxy]-5-nitro-

Description:

Pyridine, 2-[(3,4-dihydro-2-phenyl-2H-1-benzopyran-6-yl)oxy]-5-nitro- is a chemical compound characterized by its complex structure, which includes a pyridine ring and a nitro group, along with a benzopyran moiety. The presence of the nitro group typically imparts certain reactivity and polarity to the molecule, making it potentially useful in various chemical reactions and applications. The benzopyran structure contributes to its aromatic properties and may influence its biological activity. This compound may exhibit solubility in organic solvents, and its interactions with biological systems could be of interest in medicinal chemistry, particularly in the development of pharmaceuticals. Additionally, the presence of multiple functional groups suggests that it may participate in a variety of chemical reactions, including electrophilic substitutions and nucleophilic attacks. Overall, this compound's unique structural features and functional groups make it a subject of interest for further research in both synthetic and applied chemistry contexts.

Formula: C₂₀H₁₆N₂O₄

ORM-10103

CAS: 488847-28-5

ORM-10103

Purity: ≥98%

Molecular weight: 348.35g/mol

Ref: 54-BUP10879

ORM-10103

CAS: 488847-28-5

ORM-10103 is a novel potent and selective inhibitor of the Na+/Ca2+ exchanger (NCX).ORM-10103 inhibited NCX currents with estimated IC50 values of 55 and 67 nM

Formula: C₂₀H₁₆N₂O₄

Purity: 99.9%

Color and Shape: Solid

Molecular weight: 348.35

Ref: TM-T12321

ORM-10103

CAS: 488847-28-5

ORM-10103 is a medicinal compound that functions as a kinase inhibitor. It has been shown to inhibit the activity of several human kinases, including those involved in cancer and tumor growth. ORM-10103 has demonstrated potent anticancer activity in preclinical studies, inducing apoptosis in cancer cells and inhibiting their proliferation. This compound is an analog of a Chinese medicinal plant-derived protein kinase inhibitor and has shown promising results in the treatment of various types of cancer. Additionally, ORM-10103 can be detected in urine and may serve as a potential biomarker for the efficacy of kinase inhibitors in cancer therapy. With its potent anticancer properties and potential use as a biomarker, ORM-10103 represents a promising new avenue for cancer treatment research.

Formula: C₂₀H₁₆N₂O₄

Purity: Min. 95%

Molecular weight: 348.4 g/mol

Ref: 3D-NUA84728